A Study to Evaluate Remicade (Infliximab) in Moderate-to-Severe Chronic Plaque Psoriasis in the Middle Eastern Population (Study P04528)
Clinical trial NCT00687362 · COMPLETED
Trial details
- NCT number
- NCT00687362
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-05-30
- Primary completion
- 2008-11-11
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.